NUS had carried out an internal probe that started on June 30 and ended on Dec 19. Read more at straitstimes.com. Read more ...

UTIs are among the most common bacterial infections worldwide, but inappropriate use and overuse of antibiotics is driving ...

Veracyte stands out in a pressured medical instruments industry as genAI adoption and rising sales forecasts fuel investor interest.

You will be redirected to our submission process. Nanomedicine and advanced drug delivery platforms are reshaping modern therapeutics by enabling targeted, controlled, and tissue-specific delivery of ...

San Diego, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Sapu Nano today announced new biomarker data identifying a molecular signature that predicts sensitivity to Sapu003, the company’s intravenous ...

AGOURA HILLS, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) 45% owned Joint Venture, Sapu Nano today announced new biomarker data identifying a molecular ...

Nanotechnologists think the next 25 years will bring advances in quantum computing, novel materials and medicine ...

Engineered oncolytic bacteria have emerged as a promising therapeutic platform for precision cancer treatment, offering tumor-specific colonization, immune activation, and controllable therapeutic ...

VCYT, IDXX and ISRG ride on genAI-powered growth as medical instruments evolve, even with weak industry returns and cost pressures.

"All rapidly growing cells in the body are affected by chemotherapy. The cancer cells are targeted, but hair cells and the ...

A newly engineered hydrogel shows early promise for treating vocal cord injuries by persisting longer than existing injectable materials.